Explore Mesoblast Limited's advancements in cell therapies, from FDA alignments to key trials. Click for MESO opportunities ...

BRITS using the fat jab Mounjaro could be at risk of deadly organ failure due to a common mistake, an expert has warned.

Despite the global implementation of clinical algorithms designed to predict atherosclerotic cardiovascular disease based on ...

Thanks to medical advancements, heart attack deaths have dropped nearly 90% in the last 50 years. But deaths from these ...

Dr. Dustin T. Smith and Dr. Joanna M. Bonsall reviewed nine key updates in hospital medicine at SHM Converge 2025.

In this high-yield, clinically focused session, Dr. Steven L. Cohn, one of the leading experts in perioperative medicine, ...

WE’RE all aware that chest pain is a common sign that something’s wrong with our heart. But it’s far from the only signal, ...

Heart attack deaths have dropped by nearly 90% since 1970, but deaths from other heart conditions like heart failure are ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...

In 1970, ischemic heart disease—mostly heart attacks—accounted for 91% of heart-related deaths. Today, that number has fallen ...

Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care ...